For readers who have not yet heard of the peer-reviewed magazine, Oncotarget is a weekly publication. Oncotarget publishes the results of many scientific research projects on not only oncology but also other subjects having to do with medicine. Oncotarget’s parent publication is Impact Journals.
The publication put out its premiere piece roughly seven years ago. The magazine has since shared literally thousands of insightful articles. They are all in English. Follow Oncotarget on Twitter.
Oncotarget uses state of the art submission and manuscript tracking software – https://t.co/LZQlbzuW34
— Oncotarget (@OncotargetJrnl) December 14, 2017
This is due in part because the editorial staff knows that a major portion of the population of the world is able to read English. The publication is officially considered to be an “open-access journal.” basically, any scientist or research team who is interested has a chance to use the publication.
Internet sources indicated that the men who launched Oncotarget are not only qualified but also talented, and dedicated. They reportedly have a noteworthy research record as well. Oncotarget is managed by their two chief editors professors Mikhail Blagoskloklonny and Andre V. Gudkov. The publication’s team works to make certain that each article in the magazine is informative and meets the publication’s high standards of quality.
The journal’s co-editors are popular and reputable professors at the Roswell Park Cancer Institute found in Buffalo, New York. Gudkov has conducted important research in the field of cancer therapy including molecular targets and medicinal discoveries. Blagosklonny wrote over 250 different papers published in several peer-reviewed journals.
During the publication’s first year of existence, it garnered an impact factor (IF) of 4.78 and was read by people in almost 500 cities. For a new publication like this, these were impressive numbers.
One year later, the journal was in 1450 cities with a 6.636 IF. The publication was officially noted to have the “highest impact factor” of 6.727 in the year 2013. Soon the publication would be read in approximately 4,000 cities. Additionally, the peer-reviewed journal has upped its circulation to include over 30,000 cities. Overall, the general public reception of the Oncotarget journal has actually multiplied by just about 100 times during the short time it has been in publication. Visit Oncotarget’s profile page at facebook.com